Document is current
Any future updates will be listed below
-
Authors
Zhu, Yangyang
Zhang, Hao
Mao, Huawei
Zhong, Suqin
Huang, Yubing
Chen, Sirong
Yan, Kai
Zhao, Zhibin
Hao, Xiaohan
Zhang, Yue
Yao, Han
Huang, Xiaowan
Wang, Meimei
Zhang, Wenbin
Li, Juan
Meng, Guangxun https://orcid.org/0000-0003-4634-4661
Qin, Xiaohua
Ye, Zhiming
Shen, Jiani
Song, Yang
Xu, Youcui
Yang, Zhenyu
Wang, Liansheng https://orcid.org/0000-0002-4413-7530
Zhang, Yunjiao https://orcid.org/0000-0002-6465-7488
Wen, Longping https://orcid.org/0000-0003-0384-4578
- License Information
-
More Information
Article History
Received: 11 January 2022
Revised: 11 August 2022
Accepted: 22 August 2022
First Online: 14 September 2022
Competing interests
: The authors declare no competing interests.
: All mice were housed in a specific pathogen-free facility in the Laboratory Animal Center of South China University of Technology. The experiments using patient-derived PBMCs have complied with all relevant ethical regulations with the informed consent from the patients. The experiment was ethically approved by the Department of Rheumatology and Immunology, Beijing Children’s Hospital of Capital Medical University.
